Progesterone and Anxiety: The Calming Hormone and What Happens When It Drops

If you're a woman experiencing anxiety, insomnia, irritability, or a sense of inner restlessness that seems to have appeared out of nowhere — and especially if these symptoms are worse in the second half of your menstrual cycle or have worsened in your 40s — there's a hormone you need to know about.

Progesterone is one of the most potent natural anxiolytics (anti-anxiety compounds) in the human body. When progesterone levels are adequate, it produces a calm, grounded sense of wellbeing. When progesterone drops — whether cyclically, during perimenopause, or due to chronic stress — anxiety, insomnia, and emotional dysregulation often follow.

Despite this, progesterone is rarely discussed in conversations about anxiety treatment. Most women with anxiety are offered SSRIs, benzodiazepines, or therapy — without anyone checking their hormone levels. This article explains why that's a missed opportunity.

Progesterone is a steroid hormone produced primarily by the corpus luteum (the structure that forms in the ovary after ovulation) during the second half of the menstrual cycle (the luteal phase). During pregnancy, the placenta becomes the primary source of progesterone.

In non-pregnant women, progesterone:

• Rises sharply after ovulation (around day 14 of a 28-day cycle)
• Peaks around day 21
• Falls sharply if pregnancy doesn't occur, triggering menstruation
• Remains low during the follicular phase (days 1–14)

This cyclical pattern means that progesterone levels vary dramatically throughout the month — and so does its effect on mood, sleep, and anxiety.

Progesterone's anxiolytic effects are primarily mediated through its conversion to allopregnanolone (also called ALLO or 3α,5α-THP), a neurosteroid that acts as a powerful positive allosteric modulator of GABA-A receptors.

GABA (gamma-aminobutyric acid) is the brain's primary inhibitory neurotransmitter — the "brake" on neural excitability. GABA-A receptors are the same receptors targeted by benzodiazepines (Valium, Xanax, Klonopin) and alcohol. When allopregnanolone binds to these receptors, it enhances GABA's calming effect, producing:

• Reduced anxiety and fear responses
• Sedation and improved sleep
• Reduced seizure threshold
• Emotional stability
• Reduced stress reactivity

This is why progesterone is sometimes called "nature's benzodiazepine" — it works through the same receptor system, but endogenously and without the addiction risk.

The relationship between allopregnanolone and anxiety is well-established:

• Women with premenstrual dysphoric disorder (PMDD) show abnormal sensitivity to allopregnanolone fluctuations — their GABA-A receptors respond paradoxically to normal allopregnanolone changes
• Women with postpartum depression have dramatically lower allopregnanolone levels in the days after delivery (when progesterone drops precipitously)
• Brexanolone (Zulresso), the first FDA-approved treatment for postpartum depression, is a synthetic form of allopregnanolone
• Women with generalized anxiety disorder have lower luteal-phase progesterone levels than non-anxious controls

The most common pattern of progesterone-related anxiety is premenstrual — anxiety, irritability, insomnia, and emotional reactivity that worsen in the 7–14 days before menstruation and resolve within a day or two of the period starting.

This timing corresponds exactly to the rise and fall of progesterone in the luteal phase. For women with PMDD, the drop in allopregnanolone in the late luteal phase triggers a paradoxical increase in anxiety rather than the calming effect seen in most women.

Key features of premenstrual anxiety:

• Clearly cyclical — worse in the 1–2 weeks before menstruation
• Resolves with the onset of menstruation
• May include anxiety, panic attacks, insomnia, irritability, rage, or depressive symptoms
• Often dismissed as "just PMS" despite being clinically significant

Perimenopause — the transition to menopause that typically begins in the mid-40s — is characterized by erratic and declining ovarian function. Crucially, progesterone declines before estrogen in perimenopause.

As ovulation becomes irregular, the corpus luteum forms less reliably, and progesterone production falls. The result is a state of "estrogen dominance" — not because estrogen is necessarily high, but because the ratio of estrogen to progesterone is skewed.

This progesterone decline in perimenopause is associated with:

• New-onset anxiety or worsening of pre-existing anxiety
• Insomnia (progesterone has direct sleep-promoting effects)
• Irritability and emotional lability
• Heart palpitations
• Night sweats (often misattributed entirely to estrogen)
• Brain fog

Many women in their 40s are prescribed SSRIs or sleep medications for these symptoms without anyone considering that declining progesterone might be the root cause.

During pregnancy, progesterone levels rise to 10–15 times their normal levels. Within 24–48 hours of delivery, progesterone drops precipitously — one of the most dramatic hormonal shifts in human biology.

This progesterone crash is a major driver of postpartum mood disorders:

• Postpartum blues (affecting 50–80% of new mothers): transient mood instability in the first 1–2 weeks
• Postpartum depression (affecting 10–15%): persistent depression and anxiety
• Postpartum anxiety (affecting up to 20%): often more common than postpartum depression but less recognized

Chronic stress depletes progesterone through a mechanism called "pregnenolone steal" or "cortisol steal." Under chronic stress, the body preferentially converts pregnenolone (the precursor to all steroid hormones) to cortisol rather than progesterone. The result: chronically stressed women often have low progesterone even when they're not in perimenopause.

This is why anxiety and stress can become self-reinforcing: stress depletes progesterone, low progesterone reduces GABA-A activity, reduced GABA-A activity increases anxiety, and anxiety drives more stress.

Low progesterone can manifest as:

Mood and anxiety symptoms:

• Anxiety, worry, or panic attacks (especially premenstrual or perimenopausal)
• Irritability and mood swings
• Emotional sensitivity or reactivity
• Feeling "wired but tired"
• Depression (especially in the luteal phase)

Sleep symptoms:

• Difficulty falling asleep
• Waking in the middle of the night (especially 2–4 AM)
• Non-restorative sleep
• Vivid or disturbing dreams

Physical symptoms:

• Irregular or heavy periods
• Spotting before menstruation
• Breast tenderness
• Bloating
• Headaches (especially premenstrual)
• Heart palpitations

Cognitive symptoms:

• Brain fog
• Difficulty concentrating
• Memory lapses

Progesterone testing requires careful timing to be meaningful:

For cycling women: Progesterone should be tested on day 19–22 of a 28-day cycle (7 days after presumed ovulation). Testing at other times will show low levels that are normal for that phase of the cycle.

For perimenopausal women: Testing is more complex because cycles are irregular. Multiple tests across different cycle phases may be needed.

For postmenopausal women: Progesterone should be low (< 0.5 ng/mL) unless supplemented.

Optimal luteal-phase progesterone: Most functional medicine practitioners aim for 10–25 ng/mL in the mid-luteal phase for symptom relief, though "normal" lab ranges are often set lower.

At Roth Family Medicine & Mental Health, we test progesterone as part of a comprehensive hormone panel that includes estradiol, testosterone, DHEA-S, cortisol, and thyroid function — because hormones don't work in isolation.

Bioidentical progesterone (identical in molecular structure to the progesterone your body produces) is available as:

Oral progesterone (Prometrium): Taken at bedtime, oral progesterone is extensively metabolized to allopregnanolone in the gut and liver, producing strong sedative and anxiolytic effects. This makes it particularly useful for women with insomnia and anxiety. Typical doses: 100–200mg at bedtime.

Topical progesterone cream: Applied to the skin, progesterone cream provides more direct delivery with less first-pass metabolism. It produces less allopregnanolone than oral progesterone but may be preferred by women who find oral progesterone too sedating.

Vaginal progesterone: Used primarily in fertility treatment and early pregnancy support; less commonly used for anxiety and mood.

It's important to distinguish between bioidentical progesterone and synthetic progestins (medroxyprogesterone acetate, norethindrone, levonorgestrel, etc.).

Synthetic progestins do NOT convert to allopregnanolone and do NOT have the same anxiolytic, sleep-promoting effects as bioidentical progesterone. In fact, some synthetic progestins can worsen mood and anxiety. The Women's Health Initiative study, which found increased breast cancer risk with hormone therapy, used synthetic progestins — not bioidentical progesterone.

When we prescribe progesterone for mood and anxiety at Roth Family Medicine, we use bioidentical progesterone exclusively.

Several lifestyle factors support healthy progesterone production:

• Stress reduction: Chronic stress depletes progesterone via cortisol steal. Meditation, yoga, adequate sleep, and stress management directly support progesterone levels.
• Adequate body fat: Severely underweight women often have low progesterone due to hypothalamic suppression of ovulation.
• Zinc and vitamin B6: Both are required for progesterone synthesis and GABA function.
• Magnesium: Supports GABA-A receptor function and reduces anxiety independently.
• Reducing xenoestrogens: Plastics (BPA), pesticides, and certain personal care products contain compounds that mimic estrogen and may disrupt progesterone balance.

At Roth Family Medicine & Mental Health, we take a comprehensive approach to anxiety that includes hormonal assessment — because treating anxiety without addressing hormonal imbalances is like treating a plant for disease without checking the soil.

If you're a woman with anxiety, insomnia, or mood symptoms — especially if they're cyclical, worsened in perimenopause, or appeared after childbirth — a hormonal evaluation is an essential part of your workup.

We offer:

• Comprehensive hormone testing (progesterone, estradiol, testosterone, DHEA-S, cortisol, thyroid)
• Bioidentical hormone therapy individualized to your symptoms and lab results
• Integration with mental health treatment (therapy, medication, TMS, ketamine) when needed
• Ongoing monitoring and dose adjustment

You don't have to white-knuckle through anxiety that has a hormonal root cause. There are answers — and there are solutions.

Call us at (208) 904-4705 or visit us at 444 Hospital Way, Suite 422, Pocatello, Idaho 83201 to schedule a hormone consultation.

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner specializing in integrative mental health, hormone therapy, functional medicine, and advanced psychiatric treatments at Roth Family Medicine & Mental Health in Pocatello, Idaho.